Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$317.54+6.82 (+2.19%)
Close on Nov 17, 2026Market cap $120.89BP/E 33.8Yield –
Stryker total assets
Total assets on the balance sheet at the end of each period.
Stryker's total assets was $47.25B at Sep 30, 2026. For fiscal 2025 it was $47.84B, up 11.3% from the year before. Over ten years it grew 11.4% a year on average. The highest annual figure on record is $47.84B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.84B | +11.3% |
| FY2024 | Dec 31, 2024 | $42.97B | +7.7% |
| FY2023 | Dec 31, 2023 | $39.91B | +8.2% |
| FY2022 | Dec 31, 2022 | $36.88B | +6.5% |
| FY2021 | Dec 31, 2021 | $34.63B | +0.9% |
| FY2020 | Dec 31, 2020 | $34.33B | +13.8% |
| FY2019 | Dec 31, 2019 | $30.17B | +10.8% |
| FY2018 | Dec 31, 2018 | $27.23B | +22.7% |
| FY2017 | Dec 31, 2017 | $22.20B | +8.6% |
| FY2016 | Dec 31, 2016 | $20.44B | +26.0% |
| FY2015 | Dec 31, 2015 | $16.22B | -6.0% |
| FY2014 | Dec 31, 2014 | $17.26B | +12.1% |
| FY2013 | Dec 31, 2013 | $15.40B | +16.6% |
| FY2012 | Dec 31, 2012 | $13.21B | +8.7% |
| FY2011 | Dec 31, 2011 | $12.15B | +14.0% |
| FY2010 | Dec 31, 2010 | $10.66B | +17.5% |
| FY2009 | Dec 31, 2009 | $9.07B | +19.3% |
| FY2008 | Dec 31, 2008 | $7.60B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $47.25B | +0.4% |
| Q2 FY2026 | Jun 30, 2026 | $47.93B | +3.5% |
| Q1 FY2026 | Mar 31, 2026 | $46.29B | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | $47.84B | +11.3% |
| Q3 FY2025 | Sep 30, 2025 | $47.06B | +7.4% |
| Q2 FY2025 | Jun 30, 2025 | $46.33B | +18.4% |
| Q1 FY2025 | Mar 31, 2025 | $46.01B | +16.8% |
| Q4 FY2024 | Dec 31, 2024 | $42.97B | +7.7% |
| Q3 FY2024 | Sep 30, 2024 | $43.83B | +15.2% |
| Q2 FY2024 | Jun 30, 2024 | $39.13B | +4.6% |
| Q1 FY2024 | Mar 31, 2024 | $39.40B | +7.0% |
| Q4 FY2023 | Dec 31, 2023 | $39.91B | +8.2% |
| Q3 FY2023 | Sep 30, 2023 | $38.04B | +5.7% |
| Q2 FY2023 | Jun 30, 2023 | $37.41B | +3.8% |
| Q1 FY2023 | Mar 31, 2023 | $36.83B | +1.9% |
| Q4 FY2022 | Dec 31, 2022 | $36.88B | +6.5% |
| Q3 FY2022 | Sep 30, 2022 | $35.98B | +5.4% |
| Q2 FY2022 | Jun 30, 2022 | $36.03B | +6.9% |
| Q1 FY2022 | Mar 31, 2022 | $36.14B | +8.0% |
| Q4 FY2021 | Dec 31, 2021 | $34.63B | +0.9% |
| Q3 FY2021 | Sep 30, 2021 | $34.15B | +5.8% |
| Q2 FY2021 | Jun 30, 2021 | $33.70B | +7.0% |
| Q1 FY2021 | Mar 31, 2021 | $33.46B | +13.6% |
| Q4 FY2020 | Dec 31, 2020 | $34.33B | +13.8% |
| Q3 FY2020 | Sep 30, 2020 | $32.29B | +21.1% |
| Q2 FY2020 | Jun 30, 2020 | $31.48B | +19.5% |
| Q1 FY2020 | Mar 31, 2020 | $29.44B | +13.5% |
| Q4 FY2019 | Dec 31, 2019 | $30.17B | +10.8% |
| Q3 FY2019 | Sep 30, 2019 | $26.66B | +20.7% |
| Q2 FY2019 | Jun 30, 2019 | $26.35B | +22.2% |
| Q1 FY2019 | Mar 31, 2019 | $25.94B | +17.2% |
| Q4 FY2018 | Dec 31, 2018 | $27.23B | +22.7% |
| Q3 FY2018 | Sep 30, 2018 | $22.08B | +2.8% |
| Q2 FY2018 | Jun 30, 2018 | $21.57B | +1.3% |
| Q1 FY2018 | Mar 31, 2018 | $22.13B | +7.9% |
| Q4 FY2017 | Dec 31, 2017 | $22.20B | +8.6% |
| Q3 FY2017 | Sep 30, 2017 | $21.49B | – |
| Q2 FY2017 | Jun 30, 2017 | $21.29B | – |
| Q1 FY2017 | Mar 31, 2017 | $20.52B | – |
| Q4 FY2016 | Dec 31, 2016 | $20.44B | – |
See a number that looks wrong?